Immune Biosolutions is an innovative company that harnesses multiple cutting edge technologies to raise, engineer and tailor premium antibodies for diagnostic and therapeutic development.
Dedication, with a Ph. D.
Supported by a solid scientific background and a collaborative history, the Immune Biosolutions management team won many prestigious entrepreneurship and scientific awards. It is committed to combine the most rigorous scientific and business practices to provide treatments while driving growth. After validating its novel approach through partnerships and collaborations with several pharmaceutical companies in the US and Europe, Immune Biosolutions has initiated the parallel development of its own candidate antibody portfolio, with an initial focus in the areas of cancer and gastrointestinal health.
Scientific advisory board
Key opinion leaders and GPCR pioneers established in diverse fields from pharmacodynamics to clinical drug development provide scientific guidance and know-how for the strategic and technical development of therapeutic biologics. With experience in industry and academia, each board member has received more than a dozen national and international awards for achievements and scientific contributions.
Board of directors
The best of both worlds
Biotech business and financial expertise are combined to determine strategic orientations and apply the best business practices that allow to simultaneously maximize assets and drive therapeutic innovation. Partners The synergy of science and business A successful biotechnology company relies on both important financial assets and a solid scientific foundation.
The synergy of science and business
A successful biotechnology company relies on both important financial assets and a solid scientific foundation.Partners are thus essential collaborators which are carefully selected upon their ability to bring short and long term growth.